OKLAHOMA STATE DEPARTMENT OF HEALTH
NPI: 1174790513
· OKLAHOMA CITY, OK 73102
· Clinical Medical Laboratory
· NPI assigned 05/14/2008
$5.16M
Total Medicaid Paid
Provider Details
| Authorized Official | PAI, GITANJALI (CHIEF MEDICAL OFFICER) |
| NPI Enumeration Date | 05/14/2008 |
Related Entities
Other providers sharing the same authorized official: PAI, GITANJALI
Monthly Spending Trend
Yearly Breakdown
| Year | Claims | Total Paid |
|---|
| 2018 |
24,307 |
$780K |
| 2019 |
19,385 |
$549K |
| 2020 |
27,026 |
$692K |
| 2021 |
22,949 |
$661K |
| 2022 |
35,373 |
$931K |
| 2023 |
36,731 |
$1.12M |
| 2024 |
12,625 |
$429K |
Billing Codes
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
60,604 |
60,203 |
$2.15M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
60,495 |
60,098 |
$2.14M |
| 86780 |
|
21,946 |
21,722 |
$239K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
9,785 |
9,704 |
$217K |
| 86703 |
|
13,254 |
13,232 |
$117K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
3,235 |
3,231 |
$103K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,985 |
2,897 |
$96K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,490 |
1,463 |
$76K |
| 86592 |
|
3,876 |
3,787 |
$16K |
| 86701 |
|
688 |
683 |
$6K |
| 87046 |
|
13 |
13 |
$147.56 |
| 87045 |
|
13 |
13 |
$112.84 |
| 36415 |
Collection of venous blood by venipuncture |
12 |
12 |
$94.20 |